Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 17, 2026

Sep. 17, 2026

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

Indeterminate GlobeNewswire

Sep. 17, 2026

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

Indeterminate GlobeNewswire

Sep. 17, 2026

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

Indeterminate GlobeNewswire

Sep. 17, 2026

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire

Sep. 17, 2026

Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 17, 2026

Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center

Indeterminate GlobeNewswire

Sep. 17, 2026

Two Herbalists Spent Six Years Formulating an Energy Bar. Here's Why It Took That Long.

Indeterminate GlobeNewswire

Sep. 17, 2026

sensiBel Partners with X-Celeprint To Scale High-Volume Production of 80dBA SNR Optical MEMS Microphone

Indeterminate GlobeNewswire

Sep. 17, 2026

Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award

Indeterminate GlobeNewswire

Sep. 17, 2026

RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH

Indeterminate GlobeNewswire

Sep. 17, 2026

Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member

Indeterminate GlobeNewswire

Sep. 17, 2026

SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients

Indeterminate GlobeNewswire

Sep. 17, 2026

1ST Biotherapeutics and SK Biopharmaceuticals Announce Exclusive Global License Agreement for Parkinson's Disease Candidate ‘1ST-104’

Indeterminate GlobeNewswire

Sep. 17, 2026

Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice

Indeterminate GlobeNewswire

Sep. 17, 2026

Umbrella Lab Announces Documentation And Traceability Update For MOTS-C Peptide

Indeterminate GlobeNewswire

Sep. 17, 2026

Desert Hope Treatment Center Names Blaise Schafer Lead Clinician for New First Responders Program

Indeterminate GlobeNewswire

Sep. 17, 2026

MEDVi QUAD Formula Update Confirmed for 2026: Apomorphine Replaces PT-141 in Current 4-in-1 Combination

Indeterminate GlobeNewswire